Results Sensitivity and specificity ranges, respectively, for each marker were reported as
follows: BTA Stat (Polymedco), 52.5%–78.0% and 69.0%–87.1%; BTA Trak (Polymedco) …

INTRODUCTION:: The follow-up of patients with urothelial cell carcinoma (UCC) of the
bladder is done by cystoscopy and, in most cases, cytology. The last decade, many urine …

Bladder cancer is currently diagnosed using cystoscopy and cytology in patients with
suspicious signs and symptoms. These tests are also used to monitor patients with a history …

Objectives Bladder cancer detection and surveillance includes cystoscopy and cytology.
Urinary cytology is limited by its low sensitivity for low-grade tumors. Urine markers have …

This is the first of 2 articles that summarize the findings of the International Consensus Panel
on cytology and bladder tumor markers. The objectives of our panel were to reach a …

Urothelial bladder cancer is the fourth most common cancer diagnosed in males and the
ninth most common cancer in females [1]. An estimated 67 160 new cases of bladder cancer …

CONTEXT: Bladder cancer diagnosis and surveillance includes cystoscopy and cytology.
The limitation of urinary cytology is its low sensitivity for low-grade recurrences. As of now …

Multiple molecular markers have been described for use in bladder cancer patients. Some of
these have been studied more extensively than others, and it is difficult for the clinician to …

OBJECTIVES: Many markers for the detection of bladder cancers have been tested. Almost
all urinary markers reported are better than cytology with regard to sensitivity, but they score …

Early detection of bladder cancer and its recurrences is essential for improved prognosis
and long‐term survival. The detection and follow‐up of these patients is currently based on …